v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development expenses $ 25,150 $ 17,760
General and administrative expenses 8,199 8,159
Total operating expenses 33,349 25,919
Loss from operations (33,349) (25,919)
Other income (expense):    
Interest income 2,261 3,206
Interest expense 0 (2)
Other income 163 148
Other expense (9) (80)
Net loss $ (30,934) $ (22,647)
Per share information:    
Net loss per share, basic (in dollars per share) $ (1.39) $ (1.08)
Net loss per share, diluted (in dollars per share) $ (1.39) $ (1.08)
Weighted-average shares of common stock outstanding, basic (in shares) 22,305,734 20,996,287
Weighted-average shares of common stock outstanding, diluted (in shares) 22,305,734 20,996,287